Delivery Order SPE2DB22D1202-SPE2DB24FVPT1

Award Date 9/26/24
Potential Completion Date 9/27/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,372.95 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,564,590,859 units of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a ceiling value of $1,543.62. The contract is a firm fixed price delivery order with a completion date of June 16, 2025. This contract is not set aside and represents open competition. Amerisourcebergen Drug Corp is the prime contractor and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,029.07, is for the delivery of fluticasone-salmeterol 230-21 12GM pharmaceutical products. The contract is a firm fixed-price, non-set-aside, with a completion date of May 16, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $5,273.63 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of a pharmaceutical product, Fluticasone-Salmeterol 115-21 12GM. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including prescription drugs and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a firm fixed price of $1,249.44 and a completion date of June 27, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,516.15 firm fixed-price delivery order is for the supply of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $3,095.14 firm fixed price contract is for the provision of fluticasone-salmeterol 230-21 12GM pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division for the supply of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The award has a ceiling value of $2,262.75 and an ultimate completion date of August 20, 2024. The contract is a Firm Fixed Price instrument. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order, valued at $1,825.10, is for the supply of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product. The delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) awarded a $7,648.67 firm fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of Fluticasone-Salmeterol 115-21 12GM pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 between Amerisourcebergen and DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of essential...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVPT1
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,959.20 firm-fixed-price contract is for the supply of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product. The delivery order was issued under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation, and the ultimate completion date is September 27, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded numerous contracts by defense and civilian agencies to provide essential medical products, including specialty medications, generic drugs, vaccines, and medical equipment.

Generated 12/26/24, 9:20 AM